ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

CNE100001XX7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 16/07/2024 BST			5-day change	1st Jan Change
15.08 ^CNY	+3.93%		+7.25%	+27.69%

05-09	Zhejiang Garden Biopharmaceutical Co.,Ltd. Approves Final Cash Dividend on A Shares for the Year 2023, Payable on 15 May 2024	CI
04-15	Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Proposes Cash Dividend for 2016

January 23, 2017

Zhejiang Garden Bio-chemical High-tech Co., Ltd. proposed cash dividend per 10 shares (tax included) of CNY 0.50000000 for 2016.

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Garden Biopharmaceutical Co.,Ltd. Approves Final Cash Dividend on A Shares for the Year 2023, Payable on 15 May 2024	05-08	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-15	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	03-07	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has completed with 9,307,200 shares, representing 1.7% for CNY 100 million.	03-05	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Board Appointments	02-23	CI
Zhejiang Garden Biopharmaceutical's Unit Gets Nod for Eight New Products	02-05	MT
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	01-03	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/10/23	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	11/10/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 7, 2023.	14/09/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	22/08/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. authorizes a Buyback Plan.	21/08/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23	CI
Zhejiang Garden Biopharma Registers Acid Reflux Drug	04/08/23	MT
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 24, 2023	18/05/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. has Changed its Name to Zhejiang Garden Biopharmaceutical Co., Ltd	28/04/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Cash Dividend for the Year 2022	18/04/23	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2022	27/03/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. announced a financing transaction	13/02/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/10/22	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	15/08/22	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Announces 2021 Final Cash Profit Distribution Plan on A Shares, Payable on 18 May 2022	12/05/22	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Final Cash Dividend for the Year 2021	20/04/22	CI

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

More charts

Zhejiang Garden Biopharmaceutical Co Ltd, formerly Zhejiang Garden Bio-chemical High-tech Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of vitamin D3 upstream and downstream products. The Company's vitamin products mainly include lanolin cholesterol, food and pharmaceutical grade vitamin D3, 25-hydroxyvitamin D3 and others. The Company also focuses on the research and development, production and sales of high-tech barrier preparations in the fields of cardiovascular, nervous system and other chronic diseases. The other products of the Company include Levofloxacin Tablets, Doxofylline Injection, Lipoic Acid Injection, Escitalopram Oxalate Tablets and others.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.08 CNY

Average target price

15 CNY

Spread / Average Target

-0.53%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	+27.69%	1.11B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+26.12%	45.33B
OTSUKA HOLDINGS CO., LTD.	+38.49%	25.36B
SANDOZ GROUP AG	+26.90%	16.7B
CIPLA LIMITED	+20.34%	14.59B
ZYDUS LIFESCIENCES LIMITED	+71.05%	14.26B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-10.35%	6.67B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	5.62B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Equities

300401

CNE100001XX7

Pharmaceuticals

Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Proposes Cash Dividend for 2016

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals